Trials / Completed
CompletedNCT02592265
Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden
Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden and Social Participation.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 233 (actual)
- Sponsor
- Lille Catholic University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to measure economic burden of Multiple Sclerosis (MS) from a new point of view that includes consequences of disability on Quality Of Life (QOL), social participation and capabilities of patients and caregivers. To the investigators' knowledge, there is currently no data including intangible costs related to caregivers and calculating the overall economic cost of Multiple Sclerosis, particularly, in France.
Detailed description
The goal of this study is to evaluate prospectively the economic burden of Multiple Sclerosis (MS) in France by calculating direct costs (medical and non-medical) and indirect costs and by estimating consequences of MS on utility (QALY) of patients and caregivers in a societal perspective.
Conditions
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2015-08-01
- Completion
- 2016-06-01
- First posted
- 2015-10-30
- Last updated
- 2024-09-19
Source: ClinicalTrials.gov record NCT02592265. Inclusion in this directory is not an endorsement.